Why would we get distracted by rising cases, CD12 Interim, BBB, and other positive things when what we really need to do is focus on why NP and BP are upset with each other.

The future of this investment is contingent on evaluating (repeatedly) every rumor out there so we can get to the bottom of this.

Perhaps we should request a special investigator so we can get to the bottom of this immediately.

In fact, if Nasdaq does in fact approve our uplisting, I will have to file an injunction until we are able to figure out the exact cause of this rift. Nevermind the fact that both parties are trying to be professional about it, and move on. We really need to continue to obsess over this.

PS make sure to include inflammatory statements like "insanely jealous, fit of rage, and lunatic" to add more credibility to your posts. Oh, and it helps if you cite anonymous sources that you have "vetted."

Ill go first. I heard (from an unnamed, but reliable source that I verified personally via facebook) that BP is upset because NP refused to rename Leronlimab to "Pattersonlimab" Seems pretty reliable.

Obviously I am being sarcastic. (for those of you that lack the language skills to read tonality).